Metformin for Gestational Diabetes Mellitus: Progeny, Perspective, and a Personalized Approach

Abstract excerpt

Given the rapidly growing population of women diagnosed with gestational diabetes mellitus (GDM), approximating 1 in 7 pregnancies globally (1), in conjunction with the rising cost of insulins and lack of affordability (2), the popularity of using an oral agent such as metformin is expanding enormously. In fact, a number of organizations have supported its use as an alternative to insulin (3–6). However, recent...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Bariatric Surgery and Outcomes
• Share to Gestational Diabetes Research and Management
• Share to Pregnancy and preeclampsia studies